Li, Wei http://orcid.org/0000-0001-7850-9999
Kawaguchi, Kosuke http://orcid.org/0000-0002-3161-7981
Tanaka, Sunao
He, Chenfeng
Maeshima, Yurina
Suzuki, Eiji
Toi, Masakazu http://orcid.org/0000-0003-1488-9958
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21ck0106698)
Article History
Received: 22 March 2023
Accepted: 9 October 2023
First Online: 22 November 2023
Competing interests
: The authors declare the following competing interests: K.K.: grants from TERUMO, Astellas, Eli Lilly, and Kyoto Breast Cancer Research Network; consulting fees from Becton Dickinson, Japan; honoraria from Eisai, Chugai, and Takeda. M.T.: grants from Chugai, Takeda, Pfizer, Kyowa-Kirin, Taiho, JBCRG Associates, Eisai, Eli Lilly, Daiichi-Sankyo, AstraZeneca, Astellas, Shimadzu, Yakult, Nippon Kayaku, AFI Technology, Luxonus, Shionogi, and GL Science; honoraria from Chugai, Takeda, Pfizer, Kyowa-Kirin, Taiho, Eisai, Daiichi-Sankyo, AstraZeneca, Eli Lilly, MSD, Exact Science, Novartis, Konica Minolta, Shimadzu, Yakult, and Nippon Kayaku; advisory board of Kyowa-Kirin, Daiichi-Sankyo, Eli Lilly, Konica Minolta, BMS, Athenex Oncology, Bertis, Terumo, Kansai Medical Net; board of directors of JBCRG Associates, KBCRN, OOTR; Associate Editor of the <i>British Journal of Cancer</i>, <i>Scientific Reports</i>, <i>Breast Cancer Research and Treatment</i>, <i>Cancer Science</i>, <i>Frontiers in Women’s Cancer</i>, <i>Asian Journal of Surgery</i>, <i>Asian Journal of Breast Surgery</i>; deputy editor of <i>International Journal of Oncology</i>. The other authors declare no competing interests.